SCHEMBL6028720

SCHEMBL6028720

CN1CC(=O)N(c2ccc(Cl)c(Cl)c2)C1=O

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.53
MEN1 O00255 1/20 0.53
SLC6A2 P23975 2/20 0.50
SLC6A4 P31645 2/20 0.50
ADAM17 P78536 1/20 0.49
MAPT P10636 4/20 0.48
ALDH1A1 P00352 3/20 0.48
KDM4E B2RXH2 1/20 0.48
RAD51 Q06609 5/20 0.47
BCL2A1 Q16548 2/20 0.47
LMNA P02545 1/20 0.47
BCL2 P10415 1/20 0.47
ALOX12 P18054 1/20 0.47
BID P55957 1/20 0.47
BCL2L1 Q07817 1/20 0.47
BCL2L2 Q92843 1/20 0.47
CTSG P08311 2/20 0.44
CMA1 P23946 2/20 0.44
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12362750 0.86 ALDH1A1 (0.39) KMT2AMEN1SLC6A2SLC6A4ADAM17
SCHEMBL9819508 0.84 KMT2A (0.50) KMT2AMEN1SLC6A2SLC6A4ADAM17
SCHEMBL10874965 0.84 KMT2A (0.47) KMT2AMEN1SLC6A2SLC6A4ADAM17
SCHEMBL10858522 0.81 ELANE (0.47) KMT2AMEN1MAPTALDH1A1LMNA
SCHEMBL10508406 0.80 KMT2A (0.55) KMT2AMEN1MAPTALDH1A1KDM4E
SCHEMBL11656315 0.80 KMT2A (0.53) KMT2AMEN1SLC6A2SLC6A4ADAM17
SCHEMBL3838027 0.79 ALDH1A1 (0.47) KMT2AMEN1MAPTALDH1A1BCL2A1
SCHEMBL10192188 0.75 ELANE (0.57) KMT2AMEN1MAPTALDH1A1LMNA
SCHEMBL9819314 0.75 KMT2A (0.44) KMT2AMEN1SLC6A2SLC6A4ADAM17
SCHEMBL9819333 0.75 ADAM17 (0.48) KMT2AMEN1SLC6A2SLC6A4ADAM17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060182762-A1 Enterovirus, vaccines, medicaments and diagnostic kits AMSTERDAM INSTITUTE OF VIRAL GENOMICS B.V. (NL) 2006-08-17 US claimed
US-4578107-A Herbicidal imidazolidine-2-one derivatives OTSUKA KAGAKU KABUSHIKI KAISHA (JP) 1986-03-25 US disclosed
US-4345936-A Imidazoles, compositions and herbicidal method ELI LILLY AND COMPANY (US) 1982-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060182762-A1 Enterovirus, vaccines, medicaments and diagnostic kits CD99, CD63, FAM83B KMT2A 3441/4885MEN1 659/4885SLC6A2 4412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.